Skip to main content
. 2020 Jan 29;21(3):422–430. doi: 10.1111/pedi.12959

Table 1.

Summary of HNF1B mutations

GRCh37 Evidence Reference
Carrier ID coordinates Nucleotide change Protein change Classification PVS PS PM PP
9,15,19,22,28,31,34,36 Whole‐gene deletion Whole‐gene deletion pathogenic 1 4
25 17:36099540 T/‐ NM_000458.2 c.434delT NP_000449.1 p.Leu145Pro_fs_delT pathogenic 1 2 3
10 17:36099532 C/T NM_000458.2 c.443C>T NP_000449.1 p.Ser148Leu pathogenic 1,2 2 2,3 7, 18
2 17:36093617 C/T NM_000458.2 c.742C>T NP_000449.1 p.Gln248Ter pathogenic 1 1 2 1 8
16 17:36091774 T/G NM_000458.2 c.857T>G NP_000449.1 p.Leu286Arg pathogenic 2 1,2,5 2,3 22
8,20 17:36091748 C/T NM_000458.2 c.883C>T NP_000449.1:p.Arg295Cys pathogenic 1,2 1,2,5 2,3 21, 23
30 17:36093604 G/A NM_000458.2 c.755G>A NP_000449.1 p.Arg252Gln uncertain 1 2,3,5

Note: All variants were assessed according to the criteria issued by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Briefly, 14 of 15 discovered variants in HNF1B were classified as pathogenic, with whole‐gene deletions constituting about half of the findings. PVS‐very strong evidence of pathogenicity; PS‐strong evidence; PM‐moderate; PP‐supportive. Numbers indicate specific ACMG criteria.13